Abstract: Induced pluripotent stem cells (iPSC) have been generated from somatic cells by introducing reprogramming factors. Integration of foreign genes into the host genome is a technical hurdle for the clinical application. Here, we show that Sendai virus (SeV), an RNA virus and carries no risk of altering host genome, is an efcient solution for generating safe iPSC. Sendai-viral human iPSC expressed pluripotency genes, showed demethylation characteristic of reprogrammed cells. SeV-derived transgenes were decreased during cell division. Moreover, viruses were able to be easily removed by antibody-mediated negative selection utilizing cell surface marker HN that is expressed on SeV-infected cells. Viral-free iPSC dierentiated to mature cells of the three embryonic germ layers in vivo and in vitro including beating cardiomyocytes, neurons, bone and pancreatic cells. Our data demonstrated that highly-efcient, non-integrating SeV-based vector system provides a critical solution for reprogramming somatic cells and will accelerate the clinical application.
Introduction
After the report of Takahashi and Yamanaka 1) induced pluripotent stem (iPS) cells have been generated from somatic cells by transducing reprogramming factors in mammalian including mouse 1)-4) and human. 5)-9) A major limitation of this technology is the integration of viral transgenes into the host genome that includes the risk of tumorigenicity. 3) Several solutions for this problem have been developed with use of adenovirus vectors 10) or plasmids 11), 12) for induction of iPSCs, but the risk of integration still remains as far as DNA-type vectors are used. 13) These methods also suered from the low efciency of transdution. Alternative methods using a transposon, or Cre/LoxP system require subsequent excision of transgenes from the host genome. 14)-16) Use of small molecules that replace the reprogramming genes 17) may solve the problem but remain unrealized in human cells. Delivery of recombinant reprogramming proteins was able to generate iPSCs, however, the efciency was very low and needed repetitive induction. 18), 19) Considering that all those problems are derived from each of the fact that reprogramming genes have been introduced and present in the host cells as DNA form and/or the low efciency of protein expression, it is obvious that RNA virus based, and high efcient expression vector such as Sendai virus can bring an ultimate solution for those problem.
We have developed Sendai virus (SeV) vectors that replicate in the form of negative-sense singlestranded RNA in the cytoplasm of infected cells, which do not go through a DNA phase nor integrate into the host genome. 20) Since SeV vectors are very efcient for introduction of foreign genes in wide spectrum of host cell species and tissues, moreover, controllable for foreign gene expression, 21) SeV vectors have been considered for clinical studies of gene therapy for cystic brosis, 22) , 23) critical limb ischemia 24) or vaccines for AIDS. 25) In this study, we investigated whether or not Fprotein decient (ÁF), non-transmissible SeV vectors with low cytotoxity 26),27) that allow high-level expression of exogenous genes without integrating into the host genome, could be used to generate human iPSCs.
Material and methods
Cell culture. Human broblast BJ from neonatal foreskin (ATCC, USA), and HDF from facial dermis of 36-year femail (Cell Applications, Inc., USA), were maintained in broblast growth medium (Cell Applications, Inc., USA) or DMEM (Invitrogen, USA) supplemented with 10% FBS. PA6 feeder cells (RIKEN BRC, Japan) were grown in alpha-MEM (Invitrogen, USA) with 10% FBS. Human iPSCs were maintained on MMC-treated MEF feeder cells (ReproCELL, Japan) in primate ES medium (ReproCELL, Japan) supplemented with 10 ng/ml bFGF (R&D systems, USA). Human iPSCs were passaged by 1mg/ml collagenase IV (Invitrogen, USA).
Generation of SeV vectors. The open reading frames (ORFs) of human OCT3/4 were obtained from NCCIT cDNA and the ORFs of human SOX2, KLF4 and c-Myc genes were amplied from Jurkat cell cDNA by RT-PCR. Those four genes were amplied with Not I-tagged gene-specic forward primer and Not I-tagged gene-specic reverse primer containing SeV-specic transcriptional regulatory signal sequences 26) listed in Table 2 . The amplied fragment was introduced into F-decient SeV vector. Recovery and propagation of the SeV/ÁF vectors were carried out as follows. Briey, 293T cells were transfected with template pSeV/ÁF carrying each transgenes and pCAGGS-plasmids each carrying the T7 RNA polymerase, NP, P, F5R, and L gene. The cells were maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum and cultured for 1 to 3 days to generate the seed SeV/ÁF vector. Then, the vector was propagated using the LLC-MK2/F7/A cells that were Sendai virus F-expressing LLC-MK2 cells line previously established in MEM containing trypsin (2.5 mg/ml). The vector titers (cell infectious unit (CIU) per ml) of recovered SeV vector were determined by immunostaining using anti-SeV rabbit polyclonal serum described as previously. 26) Induction of pluripotent stem cells. Induction of human iPSCs was similar to previous report 5) except using SeV vectors instead of retrovirus. Alternatively, we tested feeder-free protocol: 2 Â 10 5 cells per well were plated and infected with SeV vectors at an MOI of 3 on 12 well plate, cultured in DMEM supplemented with 10% FBS. After ES-like colonies appeared, medium was changed to primate ES medium with bFGF and then growing colonies were harvested with collagenase IV treatment, plated on MEF feeder cells to avoid spontaneous dierentiation.
Determining reprogramming efciency. Reprogramming efciency was calculated as the number of iPS colonies formed per number of infected cells seeded. iPS colonies were identied based on ES-like morphology, and alkaline phosphatase staining was used to facilitate the identication of iPS colonies.
Alkaline phosphatase (ALP) and immunouorescence staining. ALP staining was performed with ALP substrate (1 step NBT/BCIP/ Pierce) after xed with 10% neutral buered formalin solution (Wako, Japan).
Immunouorescence staining was performed using the following primary antibodies: Nanog, SSEA1, SSEA4, PDX1, SOX17 (R&D systems, USA), SOX2, TH (Chemicon, USA), TRA-1-60 (BD Pharmingen, USA), TRA-1-81, OCT4, bIII-tubulin (2G10) (Santa Cruz Biotechnology, USA), anti-SeVpolyclonal antibody, 27) anti-HN-monoclonal antibody IL4.1. 28) Samples were analyzed with confocal microscopy (Bio-Rad MRC1024) or FLovel HCD-FL (Flovel, Leica). For FACS, CD34-, CD45-, CD33-PE conjugates and CD66b-FITC conjugate were purchased from BioLegend. TO-PRO3 (Molecular Probes, USA) was used for nuclear staining. 2nd antibodies used here: anti-rabbit IgG, anti-mouse IgG, IgM and ProteinA conjugated with Alexa Fluor 488 (Green) or 568 (Red) were purchased from Molecular Probes.
In vitro dierentiation of human iPSCs. Embryoid bodies were generated from clumps of human iPSCs in suspension culture for 6 days in IMDM with 15% FBS, and then grown in adherent culture on gelatin-coated dish with cytokine cocktails (100 ng/ml SCF, 100 ng/ml Flt3L, 50 ng/ml TPO, 100 ng/ml G-CSF, 20 ng/ml IGF-2, and 100 ng/ml VEGF) to induce lymphoid lineage cells and cardimyocytes. 29) For dierentiation to dopaminergic neurons, small clumps of SeV-iPSC were cocultured with PA6 (stromal cells derived from skull bone marrow; RIKEN BRC, Japan) in GMEM (Invitrogen, USA) containing 10% KSR (Invitrogen, USA), 1 Â 10 À 4 M non-essential amino acids and 2-mercaptoethanol for 16 days. 30) For induction of denitive endoderm cells and pancreatic cells, small clumps of iPSCs were cultured on feeder cells with 100 ng/ml activin A (R&D Systems, USA) in RPMI1640 (Invitrogen, USA) supplemented with 2% FBS for 4 days, and followed by additional 8 days culture in DMEM/F12 supplemented with N2 and B27, non-essential amino acids, b-mercaptoethanol, 0.5 mg/ml bovine serum albumin, L-glutamine and penicillin/streptomycin. 31) Teratoma formation by human iPSCs. Human iPSCs grown on MEF feeder layers were collected by collagenase IV treatment and injected subcutaneously into SCID mice. Palpable tumors were observed about one month after injection. Tumor samples were collected typically in two months, xed in 10% formalin, and processed for parafn embedding and hematoxylin-eosin staining following standard procedures.
Whole-genome expression analysis. For transcriptional analysis, total RNA was isolated from cells cultured in 6-well dishes using RNeasy Mini Kit. Cyanine labeled antisense RNA were amplied using Quick Amp Labeling Kit from Agilent, hybridized with Gene Expression Hybridization Kit on Whole Human Genome Oligo Microarray (one color, 4 Â 44K, Agilent, USA) and analyzed by Agilent Microarray Scanner. Data were analyzed by using GeneSpring GX10.0 software (Agilent, USA). Two normalization procedures were applied; rst, signal intensities less than 1 were set to 1. Then each chip was normalized to the 50th percentile of the measurements taken from that chip. Each gene was normalized to the median of that gene in the respective controls to enable comparison of relative changes in gene expression levels between dierent conditions. The microarray data of hES H9 cells 32) and hiPSCs 5) were retrived from GEO DataSets (GSM194390 and GSE9561, respectively). These analyses were performed at Bio Matrix Research, Inc.
Detection of telomerase activity. Telomerase activity was detected with a TRAPEZE telomerase detection kit (Chemicon, USA). The samples were separated by TBE-based 10% acrylamide nondenaturing gel electrophoresis. The gel was stained with ethidium bromide.
Bisulte genomic sequencing. Genomic DNA (1 mg) from BJ, HDF and iPSCs were treated with sodium bisulte using the BisulFast DNA Modication Kit (Toyobo, Japan) according to the manufacturer's instruction. The promoter regions of Oct4 and Nanog were amplied by PCR using primer sets previously described. 5),9) The resultant PCR products were cloned into pGEM-Teasy vector (Promega, USA) and sequenced. RNA isolation, RT-PCR, and real-time quantitative PCR analysis. Total RNA was isolated using ISOGEN (Nippon Gene, Japan) and cDNA was synthesized using the SuperScript VILO cDNA Synthesis Kit (Invitrogen, USA). Real-time PCR was performed with the ABI Prism 7700 sequence detection system (Applied Biosystems, USA) and SYBR0 Green PCR Master Mix (Applied Biosystems, USA). RT-PCR was performed with cDNAs using gene-specic primers. Primer sequences are listed in Table 2 .
DNA ngerprinting. Genomic DNA was isolated from parental broblasts, SeV vector-induced iPS clones using the DNeasy kit (Qiagen, Germany). Three variable number of tandem repeats (VNTR) loci, MCT118, D17S1290 and 3'ApoB were amplied by PCR and analysed by 3% agarose gel electrophoresis. Southern blot analysis. 10 mg of genomic DNA was digested with A II and Bam HI, or Dra I and Nco I, separated on a 1% agarose gel and blotted onto Hybond Nþ membrane (Amersham Biosciences, GE healthcare, USA). Dig-labeled probes were prepared with DIG-High Prime (Roche, Swiss) using full-length PCR products of Oct3/4, Sox2, Klf4 and c-Myc genes, respectively. The membranes were hybridized with the DIG-labeled probes and then incu- bated with the anti-DIG antibody conjugated with alkaline phosphatase conjugate. Signals were visualized with CDP-Star chemiluminescent substrate (Roche, Swiss) and the resulted chemiluminescence was detected using the LAS-1000 (FUJIFILM, Japan). Karyotyping. Cell division was blocked in mitotic metaphase using colcemid-spindle formation inhibitor (karyoMax colcemid solution, Gibco Invitrogen, USA). Nuclear membranes were broken after hypotonic treatment. For the chromosome visualization we used G-band standard staining (Giemsa, Wako, Japan).
Results
Expression of exogenous genes in human broblasts by SeV vectors. To test the efciency of the expression of exogenous genes by SeV vectors in human broblast cells, BJ from neonatal foreskin, and HDF from adult facial dermis, were infected with green uorescent protein (GFP)-carrying nontransmissible ÁF/TS-SeV vector. 26),27) Almost all the infected cells expressed GFP at low multiplicities of infection (MOI, number of viral particles per cell) of three (Fig. 1A) .
We next attempted to test the efciency of SeV vectors to transduce reprogramming factors for iPSC induction. We cloned the cDNAs for reprogramming factors, Oct3/4, Sox2, Klf4, and c-Myc 1) into ÁF/ TS-SeV vectors at dierent sites, designated 18þ, HMN, PM, MHN and L, to control the expression level (polar eect: 21) (Fig. 1B) . Since the abundance of AT-rich region decreased the expression of target 
P: passage number; PA6: doparmigenic neuron on PA6 *anti-HN-negative selection; **Tg/SeV-remained clones (P15-20) Z: positive; À: negative; e: no endoderm genes in SeV (Stuttering sequence: 23), silent mutations of the codons without replacement of amino acids were also prepared for wt c-Myc (designated rev-c-Myc). Expressions of these genes in human broblast cells by these SeV vectors were conrmed by Western blotting (Fig. 1B) . Expressions of the inserted genes decreased depending on the location of insertions: insertion at 18þ showed maximum expression while insertion at L lead to minimum expression. Anti-SeV blot showed the equivalent level of infection of each SeV vector (Fig. 1B) .
Optimization of SeV transduction for generating human iPSCs. Above results suggest that SeV vector that allows sustained expression of transgenes in a relatively controlled manner would be suitable for introducing reprogramming factors for iPSC formation. We next determined optimum conditions for applying SeV vectors to induce iPSC. Induction of human iPSC was carried out in a similar mannner described previously. 5) In brief, 1 Â 10 6 cells of BJ or HDF on 100 mm dish were infected with Oct3/4, Sox2, Klf4 and/or c-Myc by a series of SeV vectors at an MOI of 3. One week after infection, cells were collected and re-plated on mitomycin Ctreated MEF feeder cells. The next day, medium was changed to primate ES medium supplemented with 10 ng/ml bFGF. The conditions to generate SeV-iPSC performed were summarized in the column in Fig. 2A . Reprogramming efciency was calculated as the number of alkaline phosphatase (ALP)-positive, ES-like colonies formed per number of infected cells seeded (Fig. 2B) . Typical colonies were shown in Fig. 2C . Reduction in numbers of seeded cells on MEF improved the induction efciency ( Fig. 2A,  lanes 2, 3) . AT-revised c-Myc also enhanced the efciency depending on the expression level of c-Myc (rev-c-Myc: lanes 4{6). All genes inserted at HNL showed the maximum efciency, around 1% (lane 7). The efciency of reprogramming decreased approximately 100 fold when c-Myc was absent (lane 1), comparable to the result of retroviral induction without c-Myc. 33) When Klf4, but not Oct3/4 and Sox2, were moved to the other sites than 18þ or HNL, no colonies were observed (lanes 8, 9), suggesting that the balance of expression among reprogramming factors Oct3/4, Sox2 and Klf4 is a critical factor in efcient induction of reprogramming. We were also able to induce iPSCs by SeV vectors without feeder cells: (Fig. 2A, lane 10 analysis of three variable number of tandem repeats (VNTR) loci of D17S1290, MCT118 and ApoB-100 using genomic DNA from the SeV-iPS clones conrmed that these clones were originated from human broblasts BJ or HDF. B1, HNL1 and HNL5 were derived from BJ; XH1, 7H5, 7H8 and 7H10 were from HDF. B. Viral transgenes were not detected from the host genome as analyzed by genomic Southern blot. C. Karyotyping of SeV-iPSC. Viral-free SeV-iPSC HNLs at passage 34 were used for karyotyping.
Human iPSCs generated by SeV vectors (SeV-iPSCs) express hES Markers. In order to determine how many ES-like colonies fulll the more stringent criteria for iPSCs, 34) we randomly picked up ES-like colonies and established 20 clones and the results are as summarized in Table 1 . To our surprise, ES-like morphology was sufcient to select SeV-generated iPSCs that fulll typical phenotype of human ES cells. All clones expressed pluripotent markers, 34) including endogenous Oct3/4, Sox2, Nanog, GDF3, TDGF1, Zfp42, Sal4F, Dnmt3b, CABRB3, CYP26A1, FOXD3, and telomerase reverse transcriptase (hTERT), at the comparable level to the expression by human embryonic carcinoma cell line, NCCIT (Fig. 3A) . SeV-iPSC also expressed surface markers such as SSEA4 and TRA-1-60 and -81 (Fig. 3C) , high telomerase activity (Fig.  3B ) and proliferated more than six months and over 30 passages (Table 1) . DNA ngerprinting analysis 8) conrmed their broblast origin (Fig. 4A) . Taken together, SeV-vector system enables a highly efcient method to generate bona de iPSC.
SeV vectors were diluted and disappeared during cell growth. SeV vectors used here usually replicated constitutively in the cytoplasm of infected cells. 26) Thus we next analyzed the level of vector RNA in iPSCs by RT-PCR using SeV-specic primers ( Table 2) . Transgenes were expressed as early as three days after transduction (Fig. 1) , and continued to be present after iPSCs were established (Fig. 5) . However, transgenes and vectors tend to decrease over time. Fig. 5A showed our analyses on three clones that were generated with c-Myc inserted at 18þ site. Transgenes were lost at variable extent among these clones. In 4BJ1 and B1 (BJ-iPSC), Oct3/4 transgene persisted over 20 and 15 passages, whereas, in 7H5 (HDF-iPSC), Sox2 and Klf4 persisted longer. Among clones derived form vectors with c-Myc insertion at HNL, c-myc transgene usually persisted longer than other transgenes (Fig. 5A,  right panel) . This may be due to the dierence of vector replication and growth advantage of c-Myc expressing cells. However, even from those clones derived from HNL-myc vectors, we could obtain two clones that lost all viral genomes (HNLs, HNL1). shown with Wright-Giemsa staining) via embryoid bodies, 29) putative dopaminergic neurons co-expressing tyrosine hydroxylase (TH)(ectoderm), 30) denitive endoderm (Sox17), and pancreatic cells (PDX1). 31) B. In vitro dierentiation of cardiomyocytes and mononuclear cells from SeV-iPSC via embryo bodies using cytokine cocktails (SCF, Flt3L, TPO, G-CSF, IGF-2, and VEGF). 29) In the adherent culture, hematopoietic sac-like structures lled with mononuclear cells (left, upper) and beating colonies (left, middle) emerged. 29) FACS analysis shows dierentiation of SeV-iPSC to mononuclear cells (neutrophil, monocyte, and macrophage), expressing CD34, CD45, CD33, and neutrophil-specic marker CD66b (right). RT-PCR analysis shows that pluripotent marker (Nanog) was decreased and various cardiomyocytes-specic dierentiation markers (TnTc, MEF2C, MYHCB) were increased after dierentiation (left, lower). U: undierentiated; EB: embryoid body; D: dierentiated. These clones were free of viral genome and proteins (Fig. 5B, C) , carried unaltered host genome (Fig.  4B) , and karyotypically normal (Fig. 4C) . Moreover, we found that SeV-distributions were heterologous in passaged SeV-iPS colonies (Fig. 5D) . Thus, antibody against HN protein, a major protein expressed on the surface of SeV-infected cells, 20) enables us to remove HN positive cells from these heterologous populations (Fig. 5D, lower panels) . The established SeVnegative clones tested here were listed in Table 1 . From all clones, the virus can be removed by anti-HN-antibody-mediated negative selection theoretically, because SeV vectors were decreased in all clones tested (data not shown).
We selected these viral-free clones, HNL1 and HNLs, for further studies.
DNA methylation and global gene expression proles of human SeV-iPSCs. Reprogramming of methylated sites of genome is a signature of pluripotent cells. Thus, we analyzed the methylation states of CpG dinucleotides in the Oct3/4 and Nanog promoter regions by bisulte genomic sequencing. 5), 9) The result showed that Oct3/4 and Nanog promoter regions were demethylated in SeV-iPSC contrary to parental broblasts (Fig. 6A) . We also compared the gene expression prole of our SeV-iPSC with that of human H9 ES cell line and HDF iPSC line that were reported previously. 5) Our data of HNL1 is markedly similar to that of H9 ES cell lines (Fig.  6B) .
Pluripotency of SeV-iPSCs in vitro and in vivo. Dierentiation potential of viral-free SeV-iPS clones were analyzed either by in vitro embryoidbody culture or in vivo teratoma formation according to the methods described previously. 29)-31) As shown in Fig. 7A and B, we were able to induce representative mature cell lineages derived from all three germ layers; hematopoietic cells and beating cardiomyocytes for mesoderm lineage, Sox17 or PDX1 positive cells for endoderm lineage, and beta III-and tyrosine hydroxylase-positive neuron for ectodermal linage.
We further tested the pluripotency of SeV-iPSC by teratoma formation. Viral-free-iPSCs, HNL1 and HNLs from neonatal BJ and XH1 from adult HDF cells were injected subcutaneously into the anks of SCID mice. Histological examination of the teratomas revealed the presence of a set of representative tissues that were originated from the three embryonic germ layers, including neural epithelium, muscle, cartilage, bone, and glandular structures (Fig.   8 ). Remained expression of transgenes seemed to aect pluripotency (Table 1) . From the results of in vitro and in vivo dierentiation experiments, viralfree SeV-iPSC showed pluripotency.
Discussion
SeV based vectors have been used as a safe method for gene therapy, 22)-25) as SeV per se has no risk of being integrated in the host genome. In this study, we further showed that SeV is an ideal vector for generating human iPSC that fullls the latest criterion for iPSC. Firstly, as emphasized repeatedly, SeV vector allows expression of transgenes without risk of modication of host genome. Secondly, the efciency of iPSC generation by gene transduction with SeV vectors is signicantly higher than that by other methods especially without any transfection drugs. Finally, it is easy to select iPSC that depleted viral genome from the cytoplasm. Hence, resulting viral-free iPSCs become genetically intact and carries the same genome DNA as the original cells. We emphasize that the method described here has a signicant advantage over presently available methods for its safety, efciency and convenience. Nonetheless, iPS research is entering the new stage by development of methods for epigenetic reprogramming without genetic modication.
